Retatrutide (30mg)

Retatrutide is a lab-made peptide with an ambitious design: a single molecule that switches on three of the body's metabolic receptors at the same time — GLP-1, GIP and glucagon. That "triple-action" approach is newer than the single- and dual-receptor molecules that came before it, and it has made retatrutide one of the most closely watched compounds in metabolic research — in plain terms, the field most people know as weight-loss research.

Because it is still an investigational compound in clinical development — not an approved product — researchers study it to understand how activating three receptors together behaves compared with simpler designs.

What researchers study it for:

• Triple-receptor pharmacology — how one molecule hits three targets
• Metabolic and blood-sugar models — the central research area
• Energy-expenditure research — the role of the glucagon target
• Comparative studies — versus single- and dual-agonist molecules

All information here reflects published trial and preclinical research and is provided for educational, research-use-only purposes. It is not for human consumption.

Because retatrutide is still investigational and its three-receptor design is relatively new, precise identity and purity matter especially to the researchers studying it — comparisons only mean something if the starting material is exactly what it claims to be. It is generally supplied as a lyophilized powder, and every batch here is independently tested and traceable to its lot, with the certificate published before you buy.

For the full science with published studies and citations, see our retatrutide research overview.

Every batch is tested by an independent, accredited laboratory and ships with a batch-matched Certificate of Analysis (COA) you can verify before ordering — confirmed at 99% purity. For research use only. Not for human or animal consumption.